| State: | Pennsylvania |
|---|---|
| Address: | 31 Northrup Ct, Newtown, PA 18940 |
| Zip code: | 18940 |
| Phone: | (602) 889-9700 |
| Website: | https://www.acasti.com/en/contact |
Acasti Pharma Inc is located in Bucks County of Pennsylvania state. On the street of Northrup Court and street number is 31. To communicate or ask something with the place, the Phone number is (602) 889-9700. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Acasti Pharma Inc quickly are 40.2193087 ,-74.9288007
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Acasti Pharma Inc, use the form below and your opinion, advice or comment will appear in this space.
Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company's novel drug delivery technologies have the potential to improve the performance of currently marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery - all which could help to ...
https://www.acasti.com/en/investors/company-informationTo sign up for alerts on Acasti Pharma, please email or call Robert Blum at [email protected] or 602-889-9700. About Acasti Acasti Pharma Inc. (Nasdaq: ACST and TSX-V: ACST) is a late-stage ...
https://www.prnewswire.com/news-releases/acasti-pharma-inc-retains-lytham-partners-to-lead-strategic-investor-relations-and-shareholder-communication-program-301553139.htmlAcasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company's novel drug delivery technologies have the potential to improve the performance of currently…
https://www.acasti.com/en/investors/company-information/contacts602-889-9700 [email protected] ACASTI PHARMA INC. Condensed Consolidated Balance Sheet (Unaudited) ... ACASTI PHARMA INC. Condensed Consolidated Statements of Loss and Comprehensive Loss
https://www.prnewswire.com/news-releases/acasti-pharma-reports-fiscal-year-2023-operational-results-301860778.htmlAcasti Pharma Inc. (NASDAQ:ACST) Q2 2023 Earnings Conference Call November 14, 2022 1:00 PM ET. ... Should any questions remain after the call, please contact me at 602-889-9700.
https://seekingalpha.com/article/4557838-acasti-pharma-inc-acst-q2-2023-earnings-call-transcriptAcasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Conference Call February 14, 2023 1:00 PM ET. ... Should any questions remain after the call, please contact me at 602-889-9700. I'd also like to ...
https://seekingalpha.com/article/4578284-acasti-pharma-inc-acst-q3-2023-earnings-call-transcriptConference Call Details. Acasti will host a conference call on Monday, November 14, 2022, at 1:00 PM Eastern Time to discuss the Company's corporate progress and other developments, as well as financial results for its quarter ended September 30, 2022. The conference call will be available via telephone by dialing toll free 844-836-8745 for U ...
https://stockhouse.com/news/press-releases/2022/11/14/acasti-pharma-reports-second-quarter-2023-operational-resultsExplore Acasti Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 42 news, and 1 literature, Disease Domain:Endocrinology ...
https://synapse.patsnap.com/organization/e29a542a55aed874cb51f9e265a4a722Call to be held on Thursday, August 11th at 1:00 PM Eastern Time. LAVAL, Quebec, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST and TSX-V ...
https://www.globenewswire.com/news-release/2022/08/02/2490881/0/en/Acasti-Pharma-to-Report-First-Quarter-2023-Financial-Results-on-Thursday-August-11-2022.html